Search

Your search keyword '"Battegay, M"' showing total 156 results

Search Constraints

Start Over You searched for: Author "Battegay, M" Remove constraint Author: "Battegay, M" Topic humans Remove constraint Topic: humans
156 results on '"Battegay, M"'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

3. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

4. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

5. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

6. A highly virulent variant of HIV-1 circulating in the Netherlands

7. Children living with HIV in Europe: do migrants have worse treatment outcomes?

8. Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics

9. Observational cohort study of rilpivirine (RPV) utilization in Europe

10. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

11. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

12. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

13. Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

14. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

15. Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: the VIBRA cluster-randomized clinical trial

16. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

17. Healthcare delivery for HIV-positive people with tuberculosis in Europe

18. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

19. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

20. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

21. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0

22. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

23. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

24. Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

25. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

26. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

27. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients

28. Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study

29. Mortality in migrants living with HIV in western Europe (1997–2013): a collaborative cohort study

30. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

31. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people

32. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study

33. Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group

34. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

35. Liver-related death among HIV/hepatitis C virus-co-infected individuals

36. HIV resistance testing and detected drug resistance in Europe

37. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

38. Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems

39. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

40. Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes

41. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study

42. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

43. Infection-related and -unrelated malignancies, HIV and the aging population

44. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

45. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

46. Combination antiretroviral therapy and duration of pregnancy

47. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

48. Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

49. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

50. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

Catalog

Books, media, physical & digital resources